Therapy (HCV)
Genotype, Early Viral Reduction Best Indicators For Treatment Response
Published in Hepatitis Weekly, April 23rd, 2001
Hepatitis C virus (HCV) genotype also weighs in on sustained response, according to researchers.
Investigators reporting in the Scandinavian Journal of Infectious Diseases studied viral response to interferon (IFN)/ribavirin combination therapy in 20 patients initially given IFN monotherapy but who either did not respond to therapy (n=10) or relapsed after an initial response (n=10). Study participants received 12 weeks of therapy, starting with IFN,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2001-04-23)
More Articles from Hepatitis Weekly
- Hepatitis Vaccines
Oral Mucosal DNA Vaccine Good Candidate For Chronic HBV - Immunization
Infant Hepatitis B Vaccination Rate Still Down Two Years After Thimerosal Policy Statement - Epidemiology
Study Evaluates Hepatitis Viruses Among Myanmar Population - Immunization
Two-Dose Hepatitis B Vaccine Regimen Effective And Safe In Adolescents - Liver Cancer
Interferon Therapy Reduces Risk In Patients With HCV-Related Cirrhosis - Adverse Drug Effects
Potentially Fatal Heart Disorder Linked To More Than 50 Common Prescription Medications - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
